𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P-cadherin expression reduced in squamous cell carcinoma of the oral cavity : An indicator of poor prognosis

✍ Scribed by Mario Fernando Muñoz-Guerra; Eva G. Marazuela; María Encarnacíon Fernández-Contreras; Carlos Gamallo


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
271 KB
Volume
103
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Comparison of integrin, cadherin, and ca
✍ Bagutti, Claudia; Speight, Paul M.; Watt, Fiona M. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 782 KB

In addition to their role in maintenance of tissue integrity, cell adhesion molecules regulate the growth and differentiation of stratified squamous epithelia. Reduced expression of E-cadherin and the 2 1 , 3 1 and 6 4 integrins is already reported to correlate with poor histological differentiation

Endoglin (CD105) expression in squamous
✍ Ronald Schimming; Dieter Marmé 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB

## Abstract ## Background Increasing evidence suggests that endoglin (CD105) is a new powerful marker of neovascularization in solid malignancies. To explain the rating of CD105 expression in 51 squamous cell carcinoma of the oral cavity (SCCOC) we analyzed CD105 expression in tumor tissue and adj

Reduced expression of cyclin-dependent k
✍ Yasusei Kudo; Takashi Takata; Wataru Yasui; Ikuko Ogawa; Mutsumi Miyauchi; Toshi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

Reduced expression of the cyclin-dependent kinase inhibitor p27 Kip1 has been reported to correlate with poor survival in cohorts of breast and colorectal carcinoma patients. Posttranslational ubiquitin-mediated proteasomal proteolysis is related to p27 Kip1 protein levels. However, to the authors'

Expression of cell cycle markers in colo
✍ Kazuhiro Handa; Mitsunori Yamakawa; Hiroaki Takeda; Seishi Kimura; Tsuneo Takaha 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 991 KB

Our aim was to analyze the relationship between the proliferative activity of cancer cells, assessed using some cell cycle markers, and clinicopathological factors in colorectal carcinoma patients. Immunostaining for Ki-67 (pan-cell cycle marker), cyclin D1 (G 1 -phase marker) and cyclin A (S-to G 2